HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SR 27897 (Lintitript)

structure given in first source; a CCK(A) receptor antagonist
Also Known As:
Lintitript; 1-((2-(4-(2-chlorophenyl)thiazol-2-yl)aminocarbonyl)indolyl)acetic acid; SR 27897B; SR-27897; SR-27897B; 1H-Indole-1-acetic acid, 2-(((4-(2-chlorophenyl)-2-thiazolyl)amino)carbonyl)-
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Wu, Wenda: 2 articles (05/2018 - 04/2014)
2. Zhang, Haibin: 2 articles (05/2018 - 04/2014)
3. Sheng, Kun: 1 article (05/2018)
4. Xu, Xinglian: 1 article (05/2018)
5. Zhou, Guanghong: 1 article (05/2018)
6. He, Kaiyu: 1 article (04/2014)
7. Pan, Xiao: 1 article (04/2014)
8. Pestka, James J: 1 article (04/2014)
9. Sugita-Konishi, Yoshiko: 1 article (04/2014)
10. Watanabe, Maiko: 1 article (04/2014)

Related Diseases

1. Pancreatic Neoplasms (Pancreatic Cancer)
2. Anorexia
3. Tachycardia (Tachyarrhythmias)

Related Drugs and Biologics

1. Cholecystokinin Receptors (Cholecystokinin Receptor)
2. Peptides (Polypeptides)
3. Cholecystokinin B Receptor
4. T-2 Toxin (T 2 Toxin)
5. Hormones (Hormone)
6. Glucose (Dextrose)

Related Therapies and Procedures

1. Therapeutics